ALLOS THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 4th, 2005 • Allos Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 4th, 2005 Company Industry JurisdictionWHEREAS, the Investors have, pursuant to the terms of the Securities Purchase Agreement, dated as of March 2, 2005, by and among the Company and the Investors (the “Purchase Agreement”), agreed to purchase shares of Series A Exchangeable Preferred Stock, par value $0.001 per share, of the Company (the “Exchangeable Preferred Stock”); and
SECURITIES PURCHASE AGREEMENT BY AND BETWEEN THE INVESTORS LISTED ON THE SIGNATURE PAGES HERETO AND ALLOS THERAPEUTICS, INC. MARCH 2, 2005Securities Purchase Agreement • March 4th, 2005 • Allos Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 4th, 2005 Company Industry JurisdictionAllos Therapeutics, Inc., a Delaware corporation (the “Company”), hereby agrees with each of the Investors (each an “Investor” and collectively the “Investors”) listed on the signature pages to this Securities Purchase Agreement, dated as of March 2, 2005 (this “Agreement”), as follows:
February 24, 2005Placement Agent Agreement • March 4th, 2005 • Allos Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2005 Company Industry JurisdictionThis letter agreement (the “Agreement”) amends and restates in its entirety the letter agreement dated December 15, 2004 (the “Prior Agreement”) between Needham & Company, Inc. (“Needham & Company”) and Allos Therapeutics, Inc. (the “Company”). This Agreement confirms the understanding and agreement between Needham & Company and the Company as follows:
AMENDMENT TO RIGHTS AGREEMENTRights Agreement • March 4th, 2005 • Allos Therapeutics Inc • Pharmaceutical preparations
Contract Type FiledMarch 4th, 2005 Company IndustryTHIS AMENDMENT (the “Amendment”), dated as of the 4th day of March, 2005, to the Rights Agreement (the “Rights Agreement”), dated May 6, 2003, between ALLOS THERAPEUTICS, INC., a Delaware corporation (the “Company”) and MELLON INVESTOR SERVICES LLC (the “Rights Agent”), is being executed at the direction of the Company. Capitalized terms used in this Amendment and not otherwise defined herein shall have the meanings given them in the Rights Agreement.